Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex.

Area of Science:

• Biochemistry
• Hematology
• Thrombosis Research

Background:

• Understanding pathological thrombosis mechanisms distinct from hemostasis is crucial for safe antithrombotic therapies.
• The extrinsic coagulation pathway, initiated by tissue factor (TF), plays a key role in hemostasis and thrombosis.

Purpose of the Study:

• To investigate the role of the TF coagulation initiation complex in activating the intrinsic coagulation pathway.
• To elucidate a previously unrecognized TF-initiated pathway for FVIII activation and its impact on thrombus formation.

Main Methods:

• In vitro studies using TF-FVIIa complexes and FXa.
• In vivo mouse models of thrombotic lesions.
• Ex vivo studies using flowing blood and TF-FVIIa mutants.

Main Results:

• TF selectively activates FVIII, initiating the intrinsic pathway independently of thrombin feedback.
• TF-dependent FVIII activation by FXa sets the threshold for thrombus formation in a mouse model.
• A TF-FVIIa mutant complex supports FVIII-dependent thrombus formation, highlighting a prohemostatic TF-initiated pathway.

Conclusions:

• A novel TF-initiated pathway directly generates the FVIIIa-FIXa intrinsic tenase complex.
• This pathway contributes to hemostasis before thrombin amplification, offering new targets for antithrombotic strategies.